SCHEDULE 13G/A
Statement of Beneficial Ownership
Pyxis Oncology, Inc. Filed Acc 0002052113-25-003255
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| BlackRock, Inc. | 926,805 | 1.5% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G · RTW Investments, LP 9.9%
- 2026-11-16 SCHEDULE 13G · OrbiMed Capital LLC 3.6%
- 2026-11-16 SCHEDULE 13G/A · BVF PARTNERS L P/IL 9.99%
- 2026-11-03 SCHEDULE 13G/A · Laurion Capital Management LP 5.16%
- 2026-10-09 SCHEDULE 13G/A · GordonMD Global Investments LP 16.4%
- 2026-10-05 SCHEDULE 13G · Coastlands Capital LP 5.42%
- 2026-10-02 SCHEDULE 13G/A · GordonMD Global Investments LP 17.5%
- 2026-07-10 SCHEDULE 13G · BVF PARTNERS L P/IL 9.99%
- 2026-07-02 SCHEDULE 13G/A · GordonMD Global Investments LP 12.1%
- 2026-02-09 SCHEDULE 13G/A · Laurion Capital Management LP 7.72%
- 2025-10-14 SCHEDULE 13G/A · Millennium Management LLC 1.3%
- 2025-09-23 SCHEDULE 13G · GordonMD Global Investments LP 6.2%
- 2025-07-17 SCHEDULE 13G/A · BlackRock, Inc. 1.5%
- 2025-07-01 SCHEDULE 13G · Millennium Management LLC 5.7%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…